0173-0912 : Zejula 200 mg Oral Tablet, Film Coated


NDC0173-0912
Labeler: Glaxosmithkline LLC
Product Type: Human Prescription Drug
Drug Name:  Zejula
Dosage Form: Oral Tablet, Film Coated
Application #: NDA214876
Rev. Date: 


NDC Package Codes:

  • 0173-0912-13: 30 TABLET, FILM COATED IN 1 BOTTLE (0173‑0912‑13)
  • 0173-0912-61: 30 TABLET, FILM COATED IN 1 BOTTLE (0173‑0912‑61)

Active Ingredients:

  • Niraparib Tosylate Monohydrate

Dosage Strength:

  • 200 mg

Pharmaceutical Classes:

  • Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
  • Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0173-0909 Zejula 100 mg Oral Tablet, Film Coated by Glaxosmithkline LLC
  • 0173-0915 Zejula 300 mg Oral Tablet, Film Coated by Glaxosmithkline LLC
  • 69656-103 Zejula 100 mg Oral Capsule by Tesaro, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0173-0912 QR Code

< Prev: 0173-0911Next: 0173-0914 >

Related Discussions:

Zejula (Niraparib) Discussion Forum
This is my 5th week on Zejula 200mg daily. As suggested by the pharmacy nurse I take it at night to help with possible s... 4 replies
How many people in USA using Sorafenib Tosylate?
Hi, Does anyone know how many people take this medicine in USA? How about its effect? How mean generally how long it can... 2 replies




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.